This development underscores India’s commitment to supporting the Global South with affordable healthcare solutions and adds ...

Insights speaks directly to the people with an inside track on the big issues. Here, Dan Glass demands pharmaceutical company ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

Earlier this year, the FDA approved 2 new indications for Aquaflor. According to Merck, the supplemental approval increased ...

Dr. Rajiv Singh Raghuvanshi, the drug controller general of India, emphasizes the need for a diversified approach in pharmaceutical education to foster innovation and meet global health demands amid ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Store brands can save you money—and many are getting better than ever. But read the labels closely: Some aren't the bargain ...

Drugs to treat gastrointestinal and cardiovascular diseases, painkillers and anti-diabetic medicines recorded the maximum ...

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...